Lately, much has been discussed and written about buying products made only in America.

I have a 12-year-old son. This is not a unique condition. And you might think that I would be well prepared for the associated challenges, having been a 12-year-old son myself at one time. But you’d be wrong.

One of the greatest challenges that I have in discussing standards is trying to put things in a context so that all people affected by them can understand how they matter. So I want to start with a simple picture and a remarkable snapshot in time.

Industry experts at Guidon Performance Solutions’ Second Annual Virtual Healthcare Summit agreed that health care organizations’ ability to survive their increasingly demanding and changing environment will require a new agility and adaptability.

For 50 years, scientists searched for the secret to making tiny implantable devices that could travel through the bloodstream. Engineers at Stanford University have demonstrated just such a device.

For those of us practicing improvement in a medical culture, presenting this “funny new statistical way” of doing things to a physician audience triggers a predictable stated reason: “This isn’t in line with rigorous, double-blind clinical trial research.” And your r

Deciphering the Food and Drug Administration (FDA) is a bit like trying to understand what the old USSR was up to during the days of the Cold War.

Editor’s note: Umberto Tunesi is a new columnist for Quality Digest. He brings his auditing expertise to bear on a surprising range of subjects, and we’re happy to add his European perspective to our mix.

In a recent article that shall remain nameless, a statistician carefully worked out the exact answer to the wrong question. Then, based on this exact answer, he made an erroneous recommendation regarding the use of a process behavior chart for individual values.

Randomness and chaos in nature, as it turns out, can be a good thing—especially when trying to harvest energy from the movements of everyday activities.